|
David P. Perry
Chief Executive Officer
Geoffrey M. Parker
Chief Financial Officer
Kirk R. Maples, Ph.D.
Senior Vice President, Program Management
Jacob J. Plattner, Ph.D.
Senior Vice President, Research
Irwin A. Heyman, Ph.D.
Senior Vice President, Drug Development
Erik D. Wiberg
Vice President, Business Development
James R. Marconi
Vice President, Finance and Controller
Lee T. Zane, M.D.
Vice President, Clinical Development
|